Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Windecker

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Minerva Medica|October 3, 2014
Coronary revascularization and TAVI: before, during, after or never?C J O'Sullivan, G G Stefanini, S Stortecky, et al.
Circulation|March 1, 2000
Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic eventsS Windecker, A Wahl, T Chatterjee, et al.
Neurology|September 9, 2005
Prevalence and size of directly detected patent foramen ovale in migraine with auraM Schwerzmann, K Nedeltchev, F Lagger, et al.
Heart (British Cardiac Society)|January 20, 2004
Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacyM Schwerzmann, S Windecker, A Wahl, et al.
Journal of the American College of Cardiology|February 6, 1999
The influence of ventricular fibrillation duration on defibrillation efficacy using biphasic waveforms in humansS Windecker, R E Ideker, V J Plumb, et al.
Journal of Cardiovascular Electrophysiology|January 22, 1998
The effects of ventricular fibrillation duration and a preceding unsuccessful shock on the probability of defibrillation success using biphasic waveforms in pigsS Windecker, G N Kay, B H KenKnight, et al.
Neurology|April 28, 2004
Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacksM Schwerzmann, S Wiher, K Nedeltchev, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 28, 2002
Outcome of patients with cryptogenic stroke and patent foramen ovaleK Nedeltchev, M Arnold, A Wahl, et al.
Circulation|October 24, 2001
Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled studyC Seiler, T Pohl, K Wustmann, et al.
Heart (British Cardiac Society)|July 20, 2007
Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolismA Wahl, M Kunz, A Moschovitis, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Minerva Medica|October 3, 2014
Coronary revascularization and TAVI: before, during, after or never?C J O'Sullivan, G G Stefanini, S Stortecky, et al.
Circulation|March 1, 2000
Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic eventsS Windecker, A Wahl, T Chatterjee, et al.
Neurology|September 9, 2005
Prevalence and size of directly detected patent foramen ovale in migraine with auraM Schwerzmann, K Nedeltchev, F Lagger, et al.
Heart (British Cardiac Society)|January 20, 2004
Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacyM Schwerzmann, S Windecker, A Wahl, et al.
Journal of the American College of Cardiology|February 6, 1999
The influence of ventricular fibrillation duration on defibrillation efficacy using biphasic waveforms in humansS Windecker, R E Ideker, V J Plumb, et al.
Journal of Cardiovascular Electrophysiology|January 22, 1998
The effects of ventricular fibrillation duration and a preceding unsuccessful shock on the probability of defibrillation success using biphasic waveforms in pigsS Windecker, G N Kay, B H KenKnight, et al.
Neurology|April 28, 2004
Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacksM Schwerzmann, S Wiher, K Nedeltchev, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 28, 2002
Outcome of patients with cryptogenic stroke and patent foramen ovaleK Nedeltchev, M Arnold, A Wahl, et al.
Circulation|October 24, 2001
Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled studyC Seiler, T Pohl, K Wustmann, et al.
Heart (British Cardiac Society)|July 20, 2007
Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolismA Wahl, M Kunz, A Moschovitis, et al.
Pageof 4